HYDASE
Dead / Abandoned — Abandoned — no statement of use filed (as of 18 Nov 2019)
What this means for you
This application is over — abandoned 18 Nov 2019. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 86813398
- Mark type
- Stylized text
- Filed
- 09 Nov 2015
- Published for opposition
- 23 Aug 2016
- Abandoned
- 18 Nov 2019
- Attorney of record
- Mark A. Paskar
Goods and services
- Class 005 — Pharmaceuticals: Injectable pharmaceuticals, namely, hyaluronidase injections used to increase the absorption of other drugs and prevent the escape of intravenous medications into surrounding tissues; injectable drug products, namely, medical adjuvants used to facilitate and increase the dispersion and absorption of other administered medications
Owner
- Akorn, Inc., Lake Forest, IL, US
- Akorn, Inc., Lake Forest, IL, US
Prosecution history
- 19 May 2021 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 31 Mar 2021 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 18 Nov 2019 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 18 Nov 2019 — ABANDONMENT - NO USE STATEMENT FILED
- 18 Apr 2019 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 17 Apr 2019 — SOU EXTENSION 5 GRANTED
- 11 Apr 2019 — SOU EXTENSION 5 FILED
- 17 Apr 2019 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 11 Apr 2019 — SOU TEAS EXTENSION RECEIVED
- 17 Oct 2018 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 15 Oct 2018 — SOU EXTENSION 4 GRANTED
- 15 Oct 2018 — SOU EXTENSION 4 FILED
- 15 Oct 2018 — SOU TEAS EXTENSION RECEIVED
- 18 Apr 2018 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 Apr 2018 — SOU EXTENSION 3 GRANTED